A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
מצבים רפואיים
Glioblastoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Louis B Nabors, MD)University of California, San Diego, La Jolla, California, United States
Contact: Principal Investigator (David Piccioni, MD, PhD)Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States
Contact: Principal Investigator (Jethro Hu, MD)University of California, Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Phioanh Nghiemphu, MD)St. Joseph Hospital, Orange, California, United States
Contact: Principal Investigator (Lars Anker, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (UCSF Neuro Onc New Patient Coordinator) · NeuroOncNewPatientCoord@ucsf.edu · (415) 353-2193Contact: Principal Investigator (Nicholas Butowski, MD)Stanford Cancer Center, Stanford, California, United States
University of Colorado Denver, Aurora, Colorado, United States
Contact: Principal Investigator (Denise Damek, MD)Yale Cancer Center / Smilow Cancer Hospital*, New Haven, Connecticut, United States
Contact: Principal Investigator (Nicholas Blondin, MD)Mayo Clinic Cancer Center, Jacksonville, Florida, United States
Sylvester Comprehensive Cancer Center*, Miami, Florida, United States
Contact: Principal Investigator (Macarena I De La Fuente, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Patrick Grogan, MD)Piedmont Atlanta Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Erin Dunbar, MD)Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
LSU Health Sciences Center - New Orleans, New Orleans, Louisiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Patrick Wen, MD)Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Patrick Wen, MD)Henry Ford Health System, Detroit, Michigan, United States
Allina Health Systems/Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Andrea Wasilewski, MD)Mayo Clinic Cancer Center - Rochester, Rochester, Minnesota, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Perlmutter Cancer Center, NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Jonathan Yang, MD, PhD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Lyndon Kim, MD)Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Andrew Lassman, MD) · cancerclinicaltrials@cumc.columbia.edu · 212-342-0571Contact: Principal Investigator (Andrew Lassman, MD)Memorial Sloan Kettering Cancer Center*, New York, New York, United States
Contact: Principal Investigator (Ingo Mellinghoff, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Katherine Peters, MD, PhD)Comprehensive Cancer Center of Wake Forest*, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Glenn Lesser, MD)University Hospitals Cleveland Medical Center*, Cleveland, Ohio, United States
Contact: Principal Investigator (Herbert Newton, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Mina Lobbous, MD)Ohio State University Cancer Center, Columbus, Ohio, United States
University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (ACC Clinical Trials) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245Contact: Principal Investigator (Arati Desai, MD)Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Jan Drappatz, MD)Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, United States
Contact: Study coordinator (HCC Clinical Trials Office) · hcc-clinical-trials@musc.edu · 843-792-9321Contact: Principal Investigator (Scott Lindhorst, MD)Texas Oncology - Austin, Austin, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Shiao-Pei Weathers, MD)University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Principal Investigator (Howard Colman, MD, PhD)University of Virginia Health, Charlottesville, Virginia, United States
Contact: Principal Investigator (David Schiff, MD)University of Washington Medical Center, Seattle, Washington, United States
Froedtert Hospital/Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Northern Sydney Cancer Centre/Royal North Shore Hospital, St Leonards, New South Wales, Australia
Contact: Principal Investigator (Helen Wheeler, MD)Calvary Mater Newcastle, Waratah, New South Wales, Australia
Contact: Principal Investigator (Faisal Hayat, MD)Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Contact: Principal Investigator (Zarnie Lwin, MD)Flinders Medical Centre, Bedford Park, South Australia, Australia
Contact: Study coordinator (Monique Swan) · Health.FMCCancerResearchNurse@sa.gov.au · (08) 8404 2702Contact: Principal Investigator (Ganessan Kichenadasse, MD)Austin Health, Heidelberg, Victoria, Australia
Contact: Principal Investigator (Hui Gan, MBBS, FRACP, PhD)Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Principal Investigator (Jim Whittle, MD)Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (James Perry, MD, FRCPC)Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Warren Mason, MD)Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Contact: Principal Investigator (Scott Owen, MD)Université de Sherbrooke, Sherbrooke, Quebec, Canada
Centre Hospitalier Lyon Sud / Hôpital Neurologique P. Wertheimer, Bron, France
Contact: Principal Investigator (Francois Ducray, MD)Hopital de la Timone, Marseille, France
Contact: Principal Investigator (Emelie Tabouret, MD)Hopital Piti-Salpetriere, Paris, France
Contact: Principal Investigator (Mehdi Touat, MD)Uniklinik Koeln - Zentrum fuer Neurologie und Psychiatrie, Cologne, Germany
Dr. Senckenbergisches Institut für Neuroonkologie, Frankfurt, Germany
Contact: Study coordinator (Michael Ronellenfitsch, MD,PhD) · m.ronellenfitsch@med.uni-frankfurt.de · +49(0)69 6301 87711Contact: Principal Investigator (Michael Ronellenfitsch, MD, PhD)Universitätsklinik Heidelberg, Heidelberg, Germany
Contact: Principal Investigator (Antje Wick, MD)Universitaetsklinikum Heidelberg - Neurologische Klinik, Mannheim, Germany
Contact: Principal Investigator (Michael Platten, MD)Universitätsklinikum Regensburg, Regensburg, Germany
Contact: Principal Investigator (Peter Hau, MD)Universitätsklinikum Tübingen, Tübingen, Germany
Contact: Study coordinator (Ghazaleh Tabatabai) · Ghazaleh.Tabatabai@med.uni-tuebingen.de · +49 (0)707 12983269Contact: Principal Investigator (Ghazaleh Tabatabai, MD)Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne, Canton of Vaud, Switzerland
Contact: Principal Investigator (Andreas Hottinger, MD)University Hospital Zurich, Zurich, Switzerland
Contact: Principal Investigator (Michael Weller, MD)
מובילי המחקר
Tim Cloughesy, MD
Principal Investigator
GCAR CMO and GBM AGILE Global PI